Evidence that the population of quiescent bone marrow‐residing very small embryonic/epiblast‐like stem cells (VSELs) expands in response to neurotoxic treatment. Issue 9 (4th June 2014)

• Record Type: Journal Article
• Authors: Grymula, Katarzyna; Tarnowski, Maciej; Piotrowska, Katarzyna; Suszynska, Malwina; Mierzejewska, Katarzyna; Borkowska, Sylwia; Fiedorowicz, Katarzyna; Kucia, Magda; Ratajczak, Mariusz Z.
• Is Part Of: Journal of cellular and molecular medicine. Volume 18:Issue 9(2014)
• Page Start: 1797
• Page End: 1806
• Publication Date: 2014-06-04
• Subjects: Cytology; Medicine; Molecular Biology; Cytologie -- Périodiques; Médecine -- Périodiques; Biologie moléculaire -- Périodiques; Cytology -- Periodicals; Medicine -- Periodicals; Molecular biology -- Periodicals; 611.01805
• DOI: 10.1111/jcmm.12315
• Languages: English
• ISSNs: 1582-1838

Abstract

<abstract abstract-type="main" id="jcmm12315-abs-0001"> <title>Abstract</title> <p>The concept that bone marrow (BM)‐derived cells may participate in neural regeneration remains controversial, and the identity of the specific cell type(s) involved remains unknown. We recently reported that the adult murine BM contains a highly mobile population of Sca‐1⁺Lin⁻CD45⁻ cells known as very small embryonic/epiblast‐like stem cells (VSELs) that express several markers of pluripotency such as Oct‐4. In the BM microenvironment, these cells are kept quiescent because of epigenetic modification of certain paternally imprinted genes. However, as reported, these cells can be mobilized in mice in an experimental model of stroke and express several genes involved in neurogenesis while circulating in peripheral blood (PB). In the current work, we employed a model of toxic brain damage, which is induced by administration of kainic acid, to see not only whether VSELs can be mobilized into PB in response to this neurotoxin, but, more importantly, whether they proliferate and expand in BM tissue. We report here for the first time that brain damage leads to activation and expansion of the BM pool of quiescent VSELs, which precedes their subsequent egress into PB. Harnessing these cells in neural tissue regeneration is currently one of the challenges in regenerative medicine.</p> </abstract>